Drug-labels.com

Mint-Oseltamivir: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
30 mg, 45 mg, 75 mg

Patient Medication Information: uses, side effects, how to take - Mint-Oseltamivir

What is MINT-OSELTAMIVIR used for?

MINT-OSELTAMIVIR is used to treat or prevent the onset of the flu in adults and children 1 year and older.

How does MINT-OSELTAMIVIR work?

The flu (influenza) is an infection caused by influenza viruses. It is most common in the fall and winter. The flu is highly contagious. The virus usually enters the body through the mouth, nose or eyes. When a person with the flu coughs or sneezes, the virus goes into the air and can be inhaled by anyone nearby.

MINT-OSELTAMIVIR works by stopping the flu virus from spreading through your body.

When MINT-OSELTAMIVIR is taken within 2 days of you feeling symptoms of the flu, it can help you feel better sooner

When MINT-OSELTAMIVIR is taken within 2 days after coming into contact with someone with flu symptoms, it can help prevent you from getting sick with the flu.

What are the ingredients in MINT-OSELTAMIVIR?

Medicinal ingredients: oseltamivir (as oseltamivir phosphate)

Non-medicinal ingredients: Croscarmellose sodium, povidone, pregelatinized starch, sodium stearyl fumarate, and talc.

The 30 mg capsule shell contains gelatin, red iron oxide, yellow iron oxide and titanium dioxide.

The 45 mg capsule shell contains gelatin, black iron oxide and titanium dioxide.

The 75 mg capsule shell contains gelatin, black iron oxide, red iron oxide, yellow iron oxide and titanium dioxide.

Each capsule is printed with blue ink, which includes FD&C Blue No. 2 Aluminum Lake E-132 (Indigo carmine). Capsule imprinting ink also contains shellac and propylene glycol.

MINT-OSELTAMIVIR comes in the following dosage forms:

30 mg, 45 mg and 75 mg capsules

MINT-OSELTAMIVIR 30 mg capsules are available as light yellow capsules opaque cap/light yellow opaque body size ‘4’ hard gelatin capsules imprinted with ‘H’ on cap and ‘33’ on body with blue ink filled with white to off-white granular powder.

MINT-OSELTAMIVIR 45 mg capsules are available as available as grey opaque cap / grey opaque body size‘4’ hard gelatin capsules imprinted with ‘H’ on cap and ‘32’ on body with blue ink, filled with white to off white granular powder.

MINT-OSELTAMIVIR 75 mg capsules are available as light yellow opaque cap / grey opaque body size ‘2’ hard gelatin capsules imprinted with ‘H’ on cap and ‘5’ on body with blue ink, filled with white to off white granular powder.

Do not use MINT-OSELTAMIVIR if:

You are allergic or sensitive to the medicinal ingredient of MINT-OSELTAMIVIR (oseltamivir phosphate) or any other ingredient in MINT-OSELTAMIVIR (see “What are the ingredients in MINT-OSELTAMIVIR?”).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take MINT-OSELTAMIVIR. Talk about any health conditions or problems you may have, including if you:

  • Are allergic to other medicines, food and dyes
  • Have any type of kidney disease
  • Have liver disease
  • Are pregnant, plan on becoming pregnant

  • Are breast-feeding or planning to breast-feed

Tell your healthcare professional about all the medicines you take or plan on taking, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

How to take MINT-OSELTAMIVIR:

  • Your doctor has prescribed MINT-OSELTAMIVIR after diagnosing your flu condition. Other people may not benefit from taking this medicine, even though their problems may seem similar to yours. Do not give your MINT-OSELTAMIVIR to anyone else.
  • MINT-OSELTAMIVIR does not replace the flu shot. If you are at high risk of developing complications from the flu, you should continue to get your flu shot as recommended by your doctor. You may still get the flu though you got your annual flu shot.
  • It is important that you start taking MINT-OSELTAMIVIR as soon as possible from the first appearance of your flu symptoms. If your flu symptoms, most notably fever, do not begin to improve in the first day or two after you start MINT-OSELTAMIVIR, speak with your doctor.
  • MINT-OSELTAMIVIR can be taken with food. As with many medicines, if you take MINT-OSELTAMIVIR with a light snack, milk, or a meal, you may reduce possible stomach upset.

  • You must complete the entire treatment recommended by your doctor, even if you are feeling better.
  • Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than prescribed by your doctor. Never share MINT-OSELTAMIVIR with anyone, even if they have the same symptoms.
  • Note: MINT-OSELTAMIVIR is not approved for a 6 mg/mL oseltamivir oral suspension.

Usual dose:

Treatment with MINT-OSELTAMIVIR (adults, adolescents and children (1 year and older))

You should start taking MINT-OSELTAMIVIR no more than two days after flu symptoms have started. Typical symptoms of the flu include sudden onset of fever, headache, tiredness, muscular weakness, runny or stuffy nose, sore throat and cough.

  • MINT-OSELTAMIVIR should be taken twice a day (once in the morning and once in the evening) for five days.

Emergency Home Preparation of an Oral Suspension from MINT-OSELTAMIVIR Capsules:

When oseltamivir phosphate oral suspension is not available, and if directed by your doctor or pharmacist, you may mix the contents of MINT-OSELTAMIVIR capsules with sweetened liquids to prepare an oral suspension (liquid form) for children, immediately before giving to the child.

Please follow your doctor’s (or pharmacist’s) instructions carefully to ensure you are giving the right amount of medicine:

  • Holding one capsule over a small bowl, carefully pull the capsule open and pour the complete contents of the capsule into the bowl.
  • Add a small amount (no more than one teaspoon) of a sweetened liquid (such as chocolate syrup (regular or sugar- free), cherry syrup, sugar water, dessert toppings) that the child will finish.
  • Stir the mixture and give the entire amount to the child.
  • Rinse the bowl with a bit of sweetened liquid and administer the rinse to the child.
  • Repeat these steps every time you need to give the medicine.

Prevention with MINT-OSELTAMIVIR (adults, adolescents and children (1 year and older))

You should start taking MINT-OSELTAMIVIR within 2 days after coming into contact with someone with flu symptoms. Typically, about one in ten people get the flu during an outbreak, although this can change. If someone close to you (like someone living in your home) has the flu your chance of getting it yourself is higher (around one in five people).

  • MINT-OSELTAMIVIR should be taken once a day for 10 days or longer as recommended by your doctor if you have come into contact with someone who has the flu, It is important that you start taking MINT-OSELTAMIVIR as soon as possible after you were in contact.

Overdose:

If you think you, or a person you are caring for, have taken too much MINT-OSELTAMIVIR contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to take a dose of MINT-OSELTAMIVIR take it as soon as possible, then continue with the regular times you take your medication. Do not take double the amount if you miss one dose.

If you have missed several doses, inform your doctor and follow the advice given to you. Do not change your dose of MINT-OSELTAMIVIR unless instructed to do so by your doctor.

What are possible side effects from using MINT-OSELTAMIVIR?

These are not all the possible side effects you may have when taking MINT-OSELTAMIVIR. If you experience any side effects not listed here, tell your healthcare professional.

MINT-OSELTAMIVIR is generally well tolerated. The most common/possible unwanted effects are:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Headache

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
UNKNOWN
Allergic Reaction: dizziness, breathing problemsX
Liver Problems: yellowing of skin or eyes, dark urineX
Severe Skin Reaction: flushing, rash, itching, swellingX
Neurologic and Behavioural Issues (in pediatric patients): delirium (confused thinking), hallucinations, self-harm (sometimes fatal)X

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html ) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Keep out of reach and sight of children.
  • Store away from heat.
  • Keep MINT-OSELTAMIVIR capsules in their original labeled container at room temperature at 15-30°C and keep them in a dry place.
  • Do not use this medicine after the expiry date on the package or written label on the emergency compounded oral suspension.
  • Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. This will help to protect the environment.

If you want more information about MINT-OSELTAMIVIR:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website www.mintpharmaceuticals.com, or by calling 1-877-398-9696.

Last Revised: June 27, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02497441

Revision date stated in the text: June 27, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Mint-Oseltamivir

Rx or OTC
Prescription (Rx)?
DIN 02497441, 02497468, 02497476
Schedule(s) PRESCRIPTION
Active ingredient(s) Oseltamivir (oseltamivir phosphate)
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J05 Antivirals for systemic use
      1. J05A Direct acting antivirals
        1. J05AH Neuraminidase inhibitors, direct acting antivirals
          1. J05AH02 Oseltamivir
Company MINT PHARMACEUTICALS INC
Strengths and forms
DIN Strength Dosage form(s) Current status
02497441 30 MG Capsule Marketed October 18, 2023
02497468 45 MG Capsule Approved March 20, 2020
02497476 75 MG Capsule Marketed October 18, 2023

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.